Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Psycho-Social Impact of Keloid

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Tirgan, Michael H., M.D.
ClinicalTrials.gov Identifier:
NCT01478243
First received: November 20, 2011
Last updated: December 16, 2013
Last verified: December 2013

November 20, 2011
December 16, 2013
September 2012
September 2014   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01478243 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Study of Psycho-Social Impact of Keloid
Study of Psycho-Social Impact of Keloid

Despite their benign nature, keloids may constitute a severe aesthetic, and in some cases, functional problem which translates to various repercussions on person's quality of life, including much stress and insecurities.

Keloids are mostly observed between the ages of 10 and 30. Although keloid is a common condition and the investigators can make assumptions about those living with keloids, the investigators do not know the actual impact of the illness on the overall performance of patients' and how this disease, day to day, is impacting their lives. The investigators are conducting this study, aimed to investigate the psychosocial impact of keloid on daily life. Information is collected anonymously. You must be 18 years of age or older to take this survey. Parents can respond on behalf of their children who are not 18 years of age yet. The online survey will take 20-30 minutes to complete.

Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

All patients with clinical diagnosis of Keloid are invited to particiapate in this study.

Keloid
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
1000
July 2015
September 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Clinical Diagnosis of Keloid
  2. Informed consent
  3. Age above 18 to answer the survey questions
  4. Parents shall respond on behalf of their minor children
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01478243
11-07
No
Tirgan, Michael H., M.D.
Tirgan, Michael H., M.D.
Not Provided
Principal Investigator: Michael H Tirgan, MD Keloid Research Foundation
Tirgan, Michael H., M.D.
December 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP